The prescription is written. The pharmacy text says "delayed." Nobody explains which rule stopped it, so you spend the afternoon on hold guessing.
**The short answer: a stimulant prescription for ADHD passes through seven separate rules between the appointment and the counter. Each one has an owner (the prescriber, the pharmacist, the federal government, your plan) and each one has a question that unlocks it. Most delays are one rule, not a refusal. This page names the rule, who controls it, and the exact words to ask.**¹ ² ³
The seven rules, in the order you meet them
| # | The rule | Who owns it | What it means for you | Ask this |
|---|---|---|---|---|
| 1 | Telehealth prescribing. A DEA-registered prescriber may prescribe Schedule II–V medication after a telemedicine visit, with no prior in-person exam, under a temporary federal rule that runs through December 31, 2026.¹ | Federal (DEA) | An online-only prescriber is lawful today. The rule has been extended four times and could change again. | "If the telehealth rule changes, how will I keep my prescription?" |
| 2 | The CURES check. California prescribers must look up your controlled-substance history in CURES the first time they prescribe a Schedule II–IV medication and at least once every six months while it continues, within 24 hours or the previous business day before prescribing.² | Prescriber (state law) | A prescriber who asks about other pharmacies or other prescriptions is following the law, not accusing you. | "Is there anything in CURES that will slow this down?" |
| 3 | No refills on Schedule II. Stimulants such as methylphenidate and amphetamine cannot be refilled. Every fill is a new prescription. Federal rules let a prescriber write several prescriptions at once, each with an earliest fill date, for up to a 90-day supply where state law permits.³ | Prescriber / pharmacist | "Call for a refill" does not work. You need a new prescription each month unless your prescriber writes the sequence. | "Do you write 90-day sequences, and does my plan allow it?" |
| 4 | Partial fills. If the pharmacy is short, it can give what it has and owe the rest within 72 hours. A partial fill at your or your prescriber's request can be completed within 30 days of the written date where state law permits.⁴ | Pharmacist (federal rule) | A half bottle today is often available when a full bottle is not. | "Can you partial-fill and hold the balance?" |
| 5 | One transfer. Since 2023, an unfilled electronic Schedule II–V prescription may be transferred once between pharmacies at your request, pharmacist to pharmacist, staying electronic, where state law allows.⁵ | Pharmacist to pharmacist | You may not have to go back to the prescriber when Pharmacy A is out and Pharmacy B has stock. | "Will you transfer my unfilled e-prescription to a pharmacy that has it?" |
| 6 | The shortage list. FDA's Drug Shortages database is the official record. On the day this page was checked it listed amphetamine mixed salts tablets, lisdexamfetamine capsules and chewable tablets, and some methylphenidate extended-release products as currently in shortage.⁶ | Manufacturers / FDA | A shortage is a national supply fact, not a pharmacy choice. A different strength, release form or generic may be available. | "Which strengths or forms of this medicine do you have in stock?" |
| 7 | Medi-Cal Rx limits. Medi-Cal's Contract Drugs List covers common ADHD medicines, including amphetamine mixed salts, methylphenidate, dexmethylphenidate, lisdexamfetamine, atomoxetine, guanfacine ER and clonidine ER, with stimulants restricted to ADHD. Every controlled-substance claim is capped at a 35-day supply; anything longer needs prior authorization.⁷ | Medi-Cal Rx | On Medi-Cal, a 90-day fill is not an option without approval, and some brands are limited to one maker. | "Is my exact product on the Contract Drugs List, and does it need prior authorization?" |
The shortage list, product by product
FDA's Drug Shortages database is the only official record, and it changes without notice. Rather than keep a second copy of it here, the list lives on one page that is read and dated every week, with a change log: the California ADHD shortage tracker →.⁶
Two readings matter whichever page you are on. First, a dosage form is a product family, not a brand: immediate-release methylphenidate and the capsule forms have been available while the extended-release tablet was listed, which is why a prescriber can often move you to an available form the same day. Second, a product can be on the list while your pharmacy has it, or off the list while your pharmacy does not; the list describes national supply, and your pharmacist describes the shelf.
Why this is a mass problem, not a personal one
A national survey run by the CDC in late 2023 found that 6.0% of U.S. adults, about one in 16, had a current ADHD diagnosis, and that more than half of them were diagnosed as adults. One in three had taken a prescription stimulant in the past year. Of those, 71.5% had difficulty getting the prescription filled because the medication was not available. Almost half had used telehealth for ADHD care.⁸
Those numbers explain the pharmacy queue. They also explain why rules 4, 5 and 6 above matter more than they did five years ago.
Who can write the prescription
| Prescriber | Can prescribe stimulants in California? | How you get there |
|---|---|---|
| Physician (MD/DO), including your primary care doctor | Yes | Often the fastest door for uncomplicated adult ADHD. How the PCP route works → |
| Psychiatrist | Yes | If your plan is DMHC-regulated, a non-urgent specialist appointment is due within 15 business days of your request.⁹ The access rule → |
| Nurse practitioner or physician assistant with controlled-substance authority | Yes | Common in clinics and telehealth services. What a psychiatric NP is → |
| Psychologist, therapist, ADHD coach | No | They can evaluate (psychologists, therapists) or support (coaches), not prescribe. Who does what → |
Before an online service, run the five-part check on online ADHD diagnosis →. A prescription promised before the evaluation is a stop sign.
If the pharmacy says no today
Work the rules in this order. Each step takes minutes, and the printable version is on the refill and shortage checklist →.
- Ask what exactly is out — the drug, the strength, or the release form. Check it against FDA's list.⁶
- Ask for a partial fill and the date the balance will be ready.⁴
- Ask the pharmacist to call nearby pharmacies, then ask for the one-time electronic transfer.⁵
- Message your prescriber with the facts: what is in stock (different strength, immediate-release instead of extended-release, a generic). A new prescription for an available product is often same-day.
- On Medi-Cal, call Medi-Cal Rx at 800-977-2273, any hour, to confirm the product is covered and whether a prior authorization is pending.⁷
The safety line
FDA requires all prescription stimulants to carry a boxed warning about misuse, abuse, addiction and overdose, and in 2023 it updated the whole class so the warnings and patient information say the same thing across every product.¹⁰ The practical reading: keep the medicine in its own container, never share it, tell every prescriber what you take, and treat a lost bottle as a call to the prescriber, not the pharmacy. Under rule 3, a lost Schedule II bottle cannot be "refilled," and the CURES record under rule 2 will show the early request.
Q&A
Q: My pharmacy says my ADHD prescription "can't be transferred." Is that true? A: Federal rules have allowed a one-time transfer of an unfilled electronic Schedule II–V prescription since August 2023, when state law permits and the pharmacies' software supports it.⁵ Some pharmacies choose not to. If yours declines, ask the prescriber to cancel the prescription and send a new one to the pharmacy that has stock.
Q: Can I get 90 days of my stimulant at once in California? A: Not on one prescription. Federal rules let a prescriber write several sequential prescriptions covering up to a 90-day supply, each with an earliest fill date, where state law permits.³ Your plan's day-supply limit also applies, and Medi-Cal Rx caps every controlled-substance claim at 35 days.⁷
Q: Will the telehealth rule end my online prescription? A: The current federal flexibility runs through December 31, 2026.¹ Ask your prescriber now what happens if it lapses: an in-person visit with them, a hand-off to a local prescriber, or a plan they cannot yet describe. The third answer is the one to plan around.
Q: Does a therapist help with any of this? A: A therapist cannot prescribe, but ADHD-focused therapy addresses the part medicine does not: systems, follow-through, avoidance and the shame that builds around missed doses and missed refills. The whole adult ADHD decision →
Need ADHD-focused therapy alongside medication? Choose clinicians by approach, schedule and payment route → · Prepare for the evaluation first →
Sources
- U.S. Drug Enforcement Administration and Department of Health and Human Services, "Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications," Federal Register, effective January 1, 2026 through December 31, 2026 — federalregister.gov.
- Medical Board of California, "CURES Mandatory Use" fact sheet, summarizing Health and Safety Code section 11165.4 — mbc.ca.gov.
- 21 CFR 1306.12, refilling prescriptions and issuance of multiple prescriptions for Schedule II substances — ecfr.gov.
- 21 CFR 1306.13, partial filling of Schedule II prescriptions — ecfr.gov.
- 21 CFR 1306.08(e)–(f), transfer of an unfilled electronic prescription for a controlled substance between retail pharmacies — ecfr.gov.
- U.S. Food and Drug Administration, Drug Shortages database, current shortages read September 4–5, 2026 — accessdata.fda.gov.
- Medi-Cal Rx, Contract Drugs List (CDL) edition dated September 1, 2026, including the Controlled Substance Policy (35-day maximum days' supply per claim) and Customer Service Center 800-977-2273 — medi-calrx.dhcs.ca.gov.
- Staley BS, Robinson LR, Claussen AH, et al., "Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023," MMWR 73(40), October 10, 2024 — cdc.gov.
- California Department of Managed Health Care, Timely Access to Care standards — dmhc.ca.gov.
- U.S. Food and Drug Administration, "FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions," Drug Safety Communication, May 2023 — fda.gov.
Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.